Get the Stockscreener App
0.211
37.92%
-0.1289
After Hours:
.21
-0.001
-0.47%
Helius Medical Technologies Inc stock is traded at $0.211, with a volume of 13.69M.
It is down -37.92% in the last 24 hours and down -94.31% over the past month.
Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS) is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.
See More
Previous Close:
$0.3399
Open:
$0.2431
24h Volume:
13.69M
Relative Volume:
2.85
Market Cap:
$2.67M
Revenue:
$502.00K
Net Income/Loss:
$-8.86M
P/E Ratio:
-0.0372
EPS:
-5.67
Net Cash Flow:
$-10.71M
1W Performance:
-36.06%
1M Performance:
-94.31%
6M Performance:
-97.99%
1Y Performance:
-98.57%
1-Day Range:
$0.2034
$0.2499
1-Week Range:
$0.2034
$0.3835
52-Week Range:
$0.2034
$24.00
Helius Medical Technologies Inc Stock (HSDT) Company Profile
Name
Helius Medical Technologies Inc
Sector
Industry
Phone
215-944-6100
Address
642 NEWTOWN YARDLEY ROAD, NEWTOWN, PA
Compare HSDT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HSDT
Helius Medical Technologies Inc
|
0.211 | 2.67M | 502.00K | -8.86M | -10.71M | -5.67 |
|
ABT
Abbott Laboratories
|
134.38 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
106.53 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
393.55 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
86.02 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.21 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Helius Medical Technologies Inc Stock (HSDT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-24-21 | Initiated | Noble Capital Markets | Outperform |
Helius Medical Technologies Inc Stock (HSDT) Latest News
Helius Medical Technologies Secures Fifth Major Payer Authorization for PoNS Device - MSN
Helius Medical Technologies (NASDAQ:HSDT) Trading Down 17.5% – Here’s What Happened - Defense World
HSDT’s Stock Market Labyrinth: Navigating 2023’s Gains and Declines - investchronicle.com
CignaHealth becomes fifth major payer to authorize PoNS device claim By Investing.com - Investing.com India
Helius Medical Technologies, Inc. Announces Claim - GlobeNewswire
Cigna Becomes 5th Major Insurer to Cover Helius Medical's $19K Neural DeviceMajor Reimbursement Milestone - Stock Titan
Helius Shares Positive PoNSTEP Study Results on PoNS Therapy for MS - MSN
Helius Medical Secures Aetna Approval for PoNS Device Reimbursement - MSN
Helius Medical Technologies Stock Plunges 45% – Is It Time to Buy or Bail Out - thekhabrilal
Helius Medical (HSDT) Unveils Long-Term Benefits of PoNS Therapy for MS | HSDT Stock News - GuruFocus
Dow Tumbles Over 100 Points; US Producer Prices Edge Higher In May - Benzinga
Positive PoNSTEP Study Results Presented at Consortium of Multiple Sclerosis Centers Annual Meeting - GlobeNewswire
HSDTHelius Med Technologies Inc Latest Stock News & Market Updates - Stock Titan
Aetna authorizes $18,350 claim for Helius Medical’s PoNS device By Investing.com - Investing.com South Africa
Helius Medical Stock Is Soaring Wednesday: What's Going On? - Benzinga
Dow Rises Over 50 Points; US Inflation Rate Increases In May - Benzinga
Helius Medical Technologies, Inc. Announces Authorized - GlobeNewswire
Helius Medical Technologies, Inc. Announces Authorized Claim for Payment by Major Healthcare Payer for its Portable Neuromodulation Stimulator (PoNS®) Device - MarketScreener
Why Is Helius Medical Tech Stock (HSDT) Up 100% Today? - TipRanks
Aetna authorizes $18,350 claim for Helius Medical’s PoNS device - Investing.com
Helius Medical (HSDT) Secures Key Third Healthcare Provider for PoNS Reimbursement | HSDT Stock News - GuruFocus
Helius Medical announces authorized claim for payment for PoNS device - TipRanks
Helius Medical Technologies, Inc. Announces Authorized Claim for Payment by Major Healthcare - Bluefield Daily Telegraph
Major Breakthrough: Aetna Becomes Third Insurance Giant to Cover Helius Medical's MS Treatment Device - Stock Titan
Helius Medical Technologies (HSDT) Offers New Public Shares and Warrants - GuruFocus
Helius Medical Secures Nasdaq Bid Price Compliance, Eyes Equity Requirement Deadline - MSN
Why Rent the Runway Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket - Benzinga
Helius Medical Technologies stock falls after pricing capital raise of $9.1M via securities offering - MSN
Stocks Dive After Key Announcements From Helius, Mullen, And Cibus - Finimize
Helius Medical Technologies now compliant with Nasdaq minimum price rule - MSN
Top Midday Decliners - marketscreener.com
Pre-market Movers: LIMN, KRON, HSDT, CBUS... - RTTNews
Helius Medical Technologies compliant with Nasdaq price requirement - Medical Buyer
Financial Survey: Heart Tronics (OTCMKTS:HRTT) and Helius Medical Technologies (NASDAQ:HSDT) - Defense World
Helius Medical Secures $9.1M Financing: Complex Warrant Structure Offers Unique Investment Opportunity - Stock Titan
Helius Medical Technologies Announces Pricing of $9.1 Million Public Offering - Lelezard
Helius Medical regains Nasdaq minimum bid price compliance By Investing.com - Investing.com South Africa
Helius Medical Technologies Prices $9.1 Mln Public Offering - Nasdaq
Helius Medical Technologies Announces Pricing Of $9.1 Million Public Offering - marketscreener.com
Full Stock Market News from 2025-06-05 - Stock Titan
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Helius Medical Technologies, Inc. To Contact The Firm - ACCESS Newswire
Helius Medical Technologies Achieves Nasdaq Bid Price Compliance - TipRanks
Helius Medical compliant with Nasdaq bid price rule listing criteria - TipRanks
Helius Medical regains Nasdaq minimum bid price compliance - Investing.com Australia
Helius Medical (HSDT) Achieves Nasdaq Bid Price Compliance | HSDT Stock News - GuruFocus
Helius Medical Technologies, Inc. Compliant with Nasdaq Bid Price Rule Listing Criteria - The Manila Times
Helius Medical Technologies Receives Confirmation of Nasdaq Compliance for Minimum Bid Price Requirement - Nasdaq
Helius Medical Clears First Nasdaq Hurdle: What's Next for the Neurotech Company's Listing Status - Stock Titan
Helius Medical Technologies Inc Stock (HSDT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.05%
0.64%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):